156 results on '"Mohamed, Gasmi"'
Search Results
2. Osteosarcoma Pathological Classification using Statistical Features.
- Author
-
Charaf Eddine Ghenai, Mohamed Gasmi, Hakim Bendjenna, and Boulechfar Meriem
- Published
- 2024
- Full Text
- View/download PDF
3. Predictive genomic and transcriptomic analysis on endoscopic ultrasound-guided fine needle aspiration materials from primary pancreatic adenocarcinoma: a prospective multicentre studyResearch in context
- Author
-
Rémy Nicolle, Cindy Canivet, Laurent Palazzo, Bertrand Napoléon, Mira Ayadi, Camille Pignolet, Jérôme Cros, Sophie Gourgou, Janick Selves, Jérôme Torrisani, Nelson Dusetti, Pierre Cordelier, Louis Buscail, Barbara Bournet, Nicolas Carrère, Fabrice Muscari, Bertrand Suc, Rosine Guimbaud, Corinne Couteau, Marion Deslandres, Pascale Rivera, Emily Alouany, Nadim Fares, Karl Barange, Anne Gomez-Brouchet, Adrian Culetto, Guillaume Le Cosquer, Marion Jaffrelot, Bertrand Pujol, Fabien Fumex, Jérôme Desrame, Christine Lefort, Vincent Lepilliez, Rodica Gincul, Pascal Artru, Léa Clavel, Anne-Isabelle Lemaistre, Sarah Tubiana, Nicolas Flori, Pierre Senesse, Pierre-Emmanuel Colombo, Emmanuelle Samalin-Scalzi, Fabienne Portales, Lise Roca, Claire Honfo Ga, Carinne Plassot, Marc Ychou, Pierre Guibert, Christelle De La Fouchardière, Mathieu Sarabi, Patrice Peyrat, Séverine Tabone-Eglinger, Caroline Renard, Guillaume Piessen, Stéphanie Truant, Alain Saudemont, Guillaume Millet, Florence Renaud, Emmanuelle Leteurtre, Patrick Gelé, Eric Assenat, Jean-Michel Fabre, François-Régis Souche, Marie Dupuy, Anne-Marie Gorce-Dupuy, Jeanne Ramos, Jean-François Seitz, Jean Hardwigsen, Emmanuelle Norguet-Monnereau, Philippe Grandval, Muriel Duluc, Dominique Figarella-Branger, Véronique Vendrely, Clément Subtil, Eric Terrebonne, Jean-Frédéric Blanc, Jean-Philippe Merlio, Dominique Farges-Bancel, Jean-Marc Gornet, Daniela Geromin, Geoffroy Vanbiervliet, Anne-Claire Frin, Delphine Ouvrier, Marie-Christine Saint-Paul, Philippe Berthélémy, Chelbabi Fouad, Stéphane Garcia, Nathalie Lesavre, Mohamed Gasmi, Marc Barthet, Vanessa Cottet, and Cyrille Delpierre
- Subjects
Pancreatic cancer ,RNA sequencing ,Targeted DNA deep sequencing ,Translational medicine ,Predictive medicine ,Medicine ,Medicine (General) ,R5-920 - Abstract
Summary: Background: We apply endoscopic ultrasound-guided fine needle aspiration biopsy to cytopathologically diagnose and sample nucleic acids from primary tumours regardless of the disease stage. Methods: 397 patients with proven pancreatic adenocarcinoma were included and followed up in a multicentre prospective study. DNA and mRNA were extracted from materials of primary tumours obtained by endoscopic ultrasound-guided fine needle aspiration biopsy and analysed using targeted deep sequencing and RNAseq respectively. Findings: The variant allele frequency of the KRAS mutation was used to evaluate the tumour cellularity, ranging from 15 to 20% in all cells, regardless of the tumour stage. The molecular profile of metastatic primary tumours significantly differed from other types of tumours, more frequently having TP53 mutations (p = 0.0002), less frequently having RNF43 mutations, and possessing more basal-like mRNA component (p = 0.001). Molecular markers associated with improved overall survival were: mutations in homologous recombination deficiency genes in patients who received first-line platinum-based chemotherapy (p = 0.025) and wild-type TP53 gene in patients with locally advanced tumours who received radio-chemotherapy (p = 0.01). The GemPred transcriptomic profile was associated with a significantly better overall survival in patients with locally advanced or metastatic pancreatic cancer who received a gemcitabine-based first-line treatment (p = 0.019). Interpretation: The combination of genomic and transcriptomic analyses of primary pancreatic tumours enables us to distinguish metastatic tumours from other tumour types. Our molecular strategy may assist in predicting overall survival outcomes for platinum or gemcitabine-based chemotherapies, as well as radio-chemotherapy. Funding: Institut National Du Cancer (BCB INCa_7294), CHU of Toulouse, Inserm and Ligue Nationale Contre le Cancer (CIT program).
- Published
- 2024
- Full Text
- View/download PDF
4. Federated Learning with Privacy Preserving for Multi- Institutional Three-Dimensional Brain Tumor Segmentation
- Author
-
Mohammed Elbachir Yahiaoui, Makhlouf Derdour, Rawad Abdulghafor, Sherzod Turaev, Mohamed Gasmi, Akram Bennour, Abdulaziz Aborujilah, and Mohamed Al Sarem
- Subjects
brain tumor segmentation ,3D U-Net ,federated learning ,privacy-preserving ,Medicine (General) ,R5-920 - Abstract
Background and Objectives: Brain tumors are complex diseases that require careful diagnosis and treatment. A minor error in the diagnosis may easily lead to significant consequences. Thus, one must place a premium on accurately identifying brain tumors. However, deep learning (DL) models often face challenges in obtaining sufficient medical imaging data due to legal, privacy, and technical barriers hindering data sharing between institutions. This study aims to implement a federated learning (FL) approach with privacy-preserving techniques (PPTs) directed toward segmenting brain tumor lesions in a distributed and privacy-aware manner.Methods: The suggested approach employs a model of 3D U-Net, which is trained using federated learning on the BraTS 2020 dataset. PPTs, such as differential privacy, are included to ensure data confidentiality while managing privacy and heterogeneity challenges with minimal communication overhead. The efficiency of the model is measured in terms of Dice similarity coefficients (DSCs) and 95% Hausdorff distances (HD95) concerning the target areas concerned by tumors, which include the whole tumor (WT), tumor core (TC), and enhancing tumor core (ET). Results: In the validation phase, the partial federated model achieved DSCs of 86.1%, 83.3%, and 79.8%, corresponding to 95% values of 25.3 mm, 8.61 mm, and 9.16 mm for WT, TC, and ET, respectively. On the final test set, the model demonstrated improved performance, achieving DSCs of 89.85%, 87.55%, and 86.6%, with HD95 values of 22.95 mm, 8.68 mm, and 8.32 mm for WT, TC, and ET, respectively, which indicates the effectiveness of the segmentation approach, and its privacy preservation.Conclusion: This study presents a highly competitive, collaborative federated learning model with PPTs that can successfully segment brain tumor lesions without compromising patient data confidentiality. Future work will improve model generalizability and extend the framework to other medical imaging tasks.
- Published
- 2024
- Full Text
- View/download PDF
5. Semantic segmentation of breast cancer histopathology images using deep learning.
- Author
-
Yasmina Benmabrouk, Mohamed Gasmi, Hakim Bendjenna, and Abdelmouiz Nadjah
- Published
- 2022
- Full Text
- View/download PDF
6. A deep-based compound model for lung cancer detection.
- Author
-
Sourour Maalem, Mohammed Mounir Bouhamed, and Mohamed Gasmi
- Published
- 2022
- Full Text
- View/download PDF
7. Transfer Learning for the Classification of Small-Cell and Non-small-Cell Lung Cancer.
- Author
-
Mohamed Gasmi, Makhlouf Derdour, and Abdelatif Gahmous
- Published
- 2022
- Full Text
- View/download PDF
8. Transfer Learning for Highlighting Diagnosis in Pathological Anatomy Based on Immunohistochemistry.
- Author
-
Mohamed Gasmi, Issam Bendib, and Yasmina Benmabrouk
- Published
- 2021
- Full Text
- View/download PDF
9. Long-term outcome after EUS-guided radiofrequency ablation: Prospective results in pancreatic neuroendocrine tumors and pancreatic cystic neoplasms
- Author
-
Marc Barthet, Marc Giovannini, Mohamed Gasmi, Nathalie Lesavre, Christian Boustière, Bertrand Napoleon, Arthur LaQuiere, Stephane Koch, Geoffroy Vanbiervliet, and Jean-Michel Gonzalez
- Subjects
Diseases of the digestive system. Gastroenterology ,RC799-869 - Abstract
Background and study aims Endoscopic ultrasound-guided radiofrequency ablation (EUS-RFA) for pancreatic neuroendocrine tumors (NETs) and intraductal pancreatic mucinous neoplasia (IPMN) with worrisome features or high-risk stigmata (WF/HRS) has been evaluated in few series with short-term outcomes. This studyʼs primary endpoint was to assess the long-term efficacy of EUS-RFA in patients with NETs or pancreatic cystic neoplasms (PCNs) over at least 3 years. Patients and methods Twelve patients had 14 NETs with a mean 13.4-mm size (10–20) and 17 patients had a cystic tumor (16 IPMN, 1 MCA) with a 29.1-mm mean size (9–60 were included. They were treated with EUS-guided RFA, evaluated prospectively at 1 year, and followed annually for at least 3 years. Results The mean duration of follow-up was 42.9 months (36–53). Four patients died during follow-up (17–42 months) from unrelated diseases. At 1-year follow-up, and 85.7 % complete disappearance was seen in 12 patients with 14 NETs. At the end of follow-up (45.6 months), complete disappearance of tumors was seen in 85.7 % of cases. One case of late liver metastasis occurred in a patient with initial failure of EUS-RFA. At 1-year follow-up, a significant response was seen in 70.5 % of 15 patients with PCNs. At the end of the follow-up, there was a significant response in 66.6 % with no mural nodules. Two cases of distant pancreatic adenocarcinoma unrelated to IPMN occurred. Conclusions EUS-RFA results for pancreatic NETs or PCNs appear to be stable during 42 months of follow-up.
- Published
- 2021
- Full Text
- View/download PDF
10. Safety and efficacy of EUS-guided pancreatic duct drainage in symptomatic main pancreatic duct obstruction: Is there still a place for surgery?
- Author
-
Arthur Falque, Mohamed Gasmi, Marc Barthet, and Jean-Michel Gonzalez
- Subjects
Diseases of the digestive system. Gastroenterology ,RC799-869 - Abstract
Background and study aims In patients with symptomatic dilation of the main pancreatic duct (MPD) for whom endoscopic retrograde cholangiopancreatography (ERCP) is impossible, surgery has long been the only available treatment. EUS-PD is described as a minimally invasive alternative for ductal decompression surgery. We describe the results of our experience with it. Patients and methods This was a retrospective single-center study over 9 years. Twenty-seven patients, median age 61.8 years (range 36 to 85) who underwent EUS-PD for symptomatic MPD dilatation were included. The main objective was to evaluate the technical success (placement of a plastic stent between the stomach and the MPD). Secondary objectives were to document clinical success based on pain and quality of life (visual analogic scales and treatments) and complication rates, and to define a standardized management algorithm. Results The technical success rate was 92.5 %. The rate of minor adverse events was 21 % (4 cases of non-specific postoperative pain and two cases of delayed benign edematous pancreatitis). The clinical success rate was 88 %, and half of patients in whom the procedure was successful had "complete regression" of pain and half "partial regression." Median follow-up was 34.2 months (range 4 to 108). During follow-up, 74 % of patients reported improvement in quality of life and no patients required secondary surgery. Conclusion Provided it is performed in an expert center, EUS-PD is a minimally invasive, effective, and safe alternative to pancreatic surgical drainage in patients with symptomatic MPD dilatation with failure or in whom ERCP is impossible.
- Published
- 2021
- Full Text
- View/download PDF
11. Distinct epigenetic landscapes underlie the pathobiology of pancreatic cancer subtypes
- Author
-
Gwen Lomberk, Yuna Blum, Rémy Nicolle, Asha Nair, Krutika Satish Gaonkar, Laetitia Marisa, Angela Mathison, Zhifu Sun, Huihuang Yan, Nabila Elarouci, Lucile Armenoult, Mira Ayadi, Tamas Ordog, Jeong-Heon Lee, Gavin Oliver, Eric Klee, Vincent Moutardier, Odile Gayet, Benjamin Bian, Pauline Duconseil, Marine Gilabert, Martin Bigonnet, Stephane Garcia, Olivier Turrini, Jean-Robert Delpero, Marc Giovannini, Philippe Grandval, Mohamed Gasmi, Veronique Secq, Aurélien De Reyniès, Nelson Dusetti, Juan Iovanna, and Raul Urrutia
- Subjects
Science - Abstract
Pancreatic ductal adenocarcinoma (PDAC) is a complex disease and its underlying epigenomic heterogeneity is not fully understood. Here, the authors utilize patient-derived PDAC xenografts to define the epigenomic landscape of PDAC, highlighting chromatin states linked to differing disease aggressiveness and survival.
- Published
- 2018
- Full Text
- View/download PDF
12. Pancreatic Adenocarcinoma Therapeutic Targets Revealed by Tumor-Stroma Cross-Talk Analyses in Patient-Derived Xenografts
- Author
-
Rémy Nicolle, Yuna Blum, Laetitia Marisa, Celine Loncle, Odile Gayet, Vincent Moutardier, Olivier Turrini, Marc Giovannini, Benjamin Bian, Martin Bigonnet, Marion Rubis, Nabila Elarouci, Lucile Armenoult, Mira Ayadi, Pauline Duconseil, Mohamed Gasmi, Mehdi Ouaissi, Aurélie Maignan, Gwen Lomberk, Jean-Marie Boher, Jacques Ewald, Erwan Bories, Jonathan Garnier, Anthony Goncalves, Flora Poizat, Jean-Luc Raoul, Veronique Secq, Stephane Garcia, Philippe Grandval, Marine Barraud-Blanc, Emmanuelle Norguet, Marine Gilabert, Jean-Robert Delpero, Julie Roques, Ezequiel Calvo, Fabienne Guillaumond, Sophie Vasseur, Raul Urrutia, Aurélien de Reyniès, Nelson Dusetti, and Juan Iovanna
- Subjects
patient-derived xenograft ,pancreatic ductal adenocarcinoma ,genomics ,transcriptomics ,molecular subtypes ,tumor microenvironment ,Biology (General) ,QH301-705.5 - Abstract
Preclinical models based on patient-derived xenografts have remarkable specificity in distinguishing transformed human tumor cells from non-transformed murine stromal cells computationally. We obtained 29 pancreatic ductal adenocarcinoma (PDAC) xenografts from either resectable or non-resectable patients (surgery and endoscopic ultrasound-guided fine-needle aspirate, respectively). Extensive multiomic profiling revealed two subtypes with distinct clinical outcomes. These subtypes uncovered specific alterations in DNA methylation and transcription as well as in signaling pathways involved in tumor-stromal cross-talk. The analysis of these pathways indicates therapeutic opportunities for targeting both compartments and their interactions. In particular, we show that inhibiting NPC1L1 with Ezetimibe, a clinically available drug, might be an efficient approach for treating pancreatic cancers. These findings uncover the complex and diverse interplay between PDAC tumors and the stroma and demonstrate the pivotal role of xenografts for drug discovery and relevance to PDAC.
- Published
- 2017
- Full Text
- View/download PDF
13. Gene expression profiling of patient‐derived pancreatic cancer xenografts predicts sensitivity to the BET bromodomain inhibitor JQ1: implications for individualized medicine efforts
- Author
-
Benjamin Bian, Martin Bigonnet, Odile Gayet, Celine Loncle, Aurélie Maignan, Marine Gilabert, Vincent Moutardier, Stephane Garcia, Olivier Turrini, Jean‐Robert Delpero, Marc Giovannini, Philippe Grandval, Mohamed Gasmi, Mehdi Ouaissi, Veronique Secq, Flora Poizat, Rémy Nicolle, Yuna Blum, Laetitia Marisa, Marion Rubis, Jean‐Luc Raoul, James E Bradner, Jun Qi, Gwen Lomberk, Raul Urrutia, Andres Saul, Nelson Dusetti, and Juan Iovanna
- Subjects
bromodomains ,c‐MYC ,JQ1 ,pancreatic adenocarcinoma ,transcriptomic signature ,Medicine (General) ,R5-920 ,Genetics ,QH426-470 - Abstract
Abstract c‐MYC controls more than 15% of genes responsible for proliferation, differentiation, and cellular metabolism in pancreatic as well as other cancers making this transcription factor a prime target for treating patients. The transcriptome of 55 patient‐derived xenografts show that 30% of them share an exacerbated expression profile of MYC transcriptional targets (MYC‐high). This cohort is characterized by a high level of Ki67 staining, a lower differentiation state, and a shorter survival time compared to the MYC‐low subgroup. To define classifier expression signature, we selected a group of 10 MYC target transcripts which expression is increased in the MYC‐high group and six transcripts increased in the MYC‐low group. We validated the ability of these markers panel to identify MYC‐high patient‐derived xenografts from both: discovery and validation cohorts as well as primary cell cultures from the same patients. We then showed that cells from MYC‐high patients are more sensitive to JQ1 treatment compared to MYC‐low cells, in monolayer, 3D cultured spheroids and in vivo xenografted tumors, due to cell cycle arrest followed by apoptosis. Therefore, these results provide new markers and potentially novel therapeutic modalities for distinct subgroups of pancreatic tumors and may find application to the future management of these patients within the setting of individualized medicine clinics.
- Published
- 2017
- Full Text
- View/download PDF
14. Subsurface structure of Teboursouk and El Krib plains (dome zone, northern Tunisia) by gravity analysis
- Author
-
Hadhemi, Balti, Fatma, Hachani, Ali, Kadri, and Mohamed, Gasmi
- Published
- 2016
- Full Text
- View/download PDF
15. Reasoning with Vague Concepts in Description Logics.
- Author
-
Mohamed Gasmi and Mustapha Bourahla
- Published
- 2017
- Full Text
- View/download PDF
16. Risk factors for endoscopic ultrasound-guided radiofrequency ablation adverse events in patients with pancreatic neoplasms: a large national French study (RAFPAN study)
- Author
-
Bertrand Napoléon, Andrea Lisotti, Fabrice Caillol, Mohamed Gasmi, Philippe Ah-Soune, Arthur Belle, Antoine Charachon, Franck Cholet, Pierre-Yves Eyraud, Philippe Grandval, Jean-Michel Gonzalez, Francois Habersetzer, Stéphane Koch, Marc Le Rhun, Luigi Mangialavori, Nicolas Musquer, Maxime Palazzo, Laurent Poincloux, Jocelyn Privat, Adrien Sportes, Morgane Stouvenot, Clement Subtil, Lucie Thomassin, Geoffroy Vanbiervliet, Guillaume Vidal, Lucine Vuitton, Marc Giovannini, and Marc Barthet
- Subjects
Gastroenterology ,Radiology, Nuclear Medicine and imaging - Published
- 2023
- Full Text
- View/download PDF
17. Reasoning over decomposing fuzzy description logic.
- Author
-
Mohamed Gasmi and Mustapha Bourahla
- Published
- 2016
- Full Text
- View/download PDF
18. Security architecture metamodel for Model Driven security.
- Author
-
Derdour Makhlouf, Adel Alti, Mohamed Gasmi, and Philippe Roose
- Published
- 2015
- Full Text
- View/download PDF
19. How to do EUS‐guided Radiofrequency Ablation of Pancreatic Neuroendocrine Tumors
- Author
-
Marc Barthet, Mohamed Gasmi, and Jean‐Michel Gonzalez
- Published
- 2021
- Full Text
- View/download PDF
20. Endoscopic ultra-sound (EUS) guided management of symptomatic pelvic collections: puncture-aspiration or drainage? Results from mono-centric retrospective experience with therapeutic algorithm
- Author
-
Marine Guingand, Marc Barthet, Jean-Michel Gonzalez, Mélanie Serrero, and Mohamed Gasmi
- Subjects
Adult ,medicine.medical_specialty ,Clinical effectiveness ,medicine.medical_treatment ,Therapeutic algorithm ,Punctures ,Endosonography ,Sigmoiditis ,medicine ,Humans ,Adverse effect ,Retrospective Studies ,Crohn's disease ,business.industry ,Gastroenterology ,Stent ,medicine.disease ,digestive system diseases ,Surgery ,Treatment Outcome ,Drainage ,Stents ,Observational study ,Ultra sound ,business ,Algorithms - Abstract
BACKGROUND Pelvic collections may occur after surgery or in medical diseases. EUS transmural (TM) treatment has been shown as highly effective and safe, becoming an alternative to surgery or radiology. We aimed to assess the results of EUS management of pelvic collections. METHODS Retrospective, single-center observational study conducted between 2004 and 2018. Patients with symptomatic collections treated by EUS-TM approach were enrolled. The procedures were performed with a therapeutic EUS-scope, following two possible options: puncture-aspiration-injection of antibiotics PAIA (group 1) or EUS-drainage by plastic double pigtail stents (DPS) with an ano-cavitary drain (ACD) or lumen-apposing metal Stent (LAMS) (group 2). The main objective was to assess the clinical effectiveness based on symptoms and collection resolution. RESULTS Seventy-three patients were included. Mean age was 42.5 years [12-87]. 30 patients in group 1 (41%) underwent PAIA and 43 in group 2 (59%) underwent DPS ± ACD in 41 patients (95%) and LAMS in 2. The collection was postoperative in 58%. The mean size was 48.9 mm [8-120], 33 +/- 17 mm in group 1, compared to 67 ± 21 mm in group 2 (p
- Published
- 2021
- Full Text
- View/download PDF
21. Candy cane syndrome: a new endoscopic treatment for this underappreciated surgical complication
- Author
-
Sohaib Ouazzani, Mohamed Gasmi, Jean-Michel Gonzalez, and Marc Barthet
- Subjects
Gastroenterology - Published
- 2023
- Full Text
- View/download PDF
22. Contribution of electrical prospecting to the structural study of the Oued Gueniche plain (Northern Tunisia): hydrogeological implications
- Author
-
Sabrine Zaghdoudi, Mouna Ben Alayet, Abdelwahab Aydi, Amal Ghouma, and Mohamed Gasmi
- Subjects
General Earth and Planetary Sciences ,General Environmental Science - Published
- 2022
- Full Text
- View/download PDF
23. Contribution of electrical prospecting to the aquifer characterization in El Mouazir-Matmata Nouvelle in Southern Gabes, Southeastern Tunisia
- Author
-
Hajer Aydi, Hadhemi Balti, Abdelwaheb Aydi, and Mohamed Gasmi
- Subjects
General Earth and Planetary Sciences ,General Environmental Science - Published
- 2022
- Full Text
- View/download PDF
24. RETRACTED: Expression of adrenomedullin in human colorectal tumors and its role in cell growth and invasion in vitro and in xenograft growth in vivo
- Author
-
Emilie Nouguerède, Caroline Berenguer, Stéphane Garcia, Bahia Bennani, Christine Delfino, Isabelle Nanni, Laetitia Dahan, Mohamed Gasmi, Jean‐François Seitz, Pierre‐Marie Martin, and L'Houcine Ouafik
- Subjects
Adrenomedullin ,AM1 and AM2 receptors ,angiogenesis ,colorectal cancer ,tumor growth ,Neoplasms. Tumors. Oncology. Including cancer and carcinogens ,RC254-282 - Abstract
Abstract Adrenomedullin (AM) is a multifunctional peptide vasodilator that transduces its effects through calcitonin receptor‐like receptor/receptor activity‐modifying protein‐2 and ‐3 (CLR/RAMP2 and CLR/RAMP3). In this study, real‐time quantitative reverse transcription demonstrated a significant expression of AM mRNA in tumor samples from colorectal cancer (CRC) patients in clinical stage II, III, and IV when compared with normal colorectal tissue. AM, CLR, RAMP2, and RAMP3 proteins were immunohistochemically localized in the carcinomatous epithelial compartment of CRC tissue. Tissue microarray analysis revealed a clear increase of AM, CLR, RAMP2, and RAMP3 staining in lymph node and distant metastasis when compared with primary tumors. The human colon carcinoma cells HT‐29 expressed and secreted AM into the culture medium with a significant increase under hypoxia. Treatment of HT‐29 cells with synthetic AM stimulated cell proliferation and invasion in vitro. Incubation with anti‐AM antibody (αAM), anti‐AM receptors antibodies (αAMR), or AM antagonist AM22–52 inhibited significantly basal levels of proliferation of HT‐29 cells, suggesting that AM may function as an autocrine growth factor for CRC cells. Treatment with αAM significantly suppressed the growth of HT‐29 tumor xenografts in vivo. Histological examination of αAM‐treated tumors showed evidence of disruption of tumor vascularity with decreased microvessel density, depletion of endothelial cells and pericytes, and increased tumor cell apoptosis. These findings highlight the potential importance of AM and its receptors in the progression of CRC and support the conclusion that αAM treatment inhibits tumor growth by suppression of angiogenesis and tumor growth, suggesting that AM may be a useful therapeutic target.
- Published
- 2013
- Full Text
- View/download PDF
25. Health risk assessment associated to heavy metal pollution levels in Mediterranean environment soils: a case study in the watershed of Sebkhet Ariana, Tunisia
- Author
-
Amal Ghouma, Abdelwaheb Aydi, Jose Antonio Rodriguez Martin, and Mohamed Gasmi
- Subjects
General Earth and Planetary Sciences ,General Environmental Science - Published
- 2022
26. Impacted and Fractured Biliary Basket: A Second Basket Rescue Technique
- Author
-
Mohammed Amine Benatta, Ariane Desjeux, Marc Barthet, Jean Charles Grimaud, and Mohamed Gasmi
- Subjects
Medicine - Abstract
A 59-year-old woman was treated with ERCP, ES, and biliary plastic stent, for large and multiple common bile duct stones. During a second ERCP basket extraction was impacted with a round entrapped stone. The basket handle was cut off; a metal sheath of extraendoscopic lithotriptor was advanced over the basket. The mechanical lithotripsy was complicated with basket traction wires fracturing, without breakage of the stone. A rescue standard basket was pushed until it caught the basket/stone complex. Using this method disengagement of the whole fractured basket/stone complex was achieved without need of surgery. It is the third case reported in the English literature.
- Published
- 2016
- Full Text
- View/download PDF
27. Multi-Input CNN for molecular classification in breast cancer
- Author
-
Mohamed Amroune, Hakim Bendjenna, Brahim Sahraoui, Mohamed Gasmi, Makhlouf Derdour, and Abdellatif Gahmousse
- Subjects
Cancer classification ,Computer science ,business.industry ,Cancer ,Pattern recognition ,medicine.disease ,Pathological anatomy ,Convolutional neural network ,Data modeling ,Breast cancer ,Molecular classification ,Multi input ,medicine ,Artificial intelligence ,business - Abstract
Molecular classification in pathological anatomy is an important task as it is extremely convenient for the diagnosis of cancer and its subtypes for adequate therapeutic choice. With the development of computer vision, cancer classification has become an interdisciplinary subject in both medicine and computer vision.A multi-input convolutional neural network is designed for the molecular classification of cancer based on a collected dataset, which contains four tissues treated with four antibodies; each one of them is composed of 33 images. The proposed model achieves a satisfactory accuracy of 90.43% after data augmentation. Even though the data augmentation contributes to the model, the accuracy is still limited by the lack of sample diversity.
- Published
- 2021
- Full Text
- View/download PDF
28. Predictive factors for early progression during induction chemotherapy and chemotherapy-free interval: analysis from PRODIGE 9 trial
- Author
-
Jean-Marc Phelip, Valérie Boige, Karine Le Malicot, Julien Taieb, Jean-Marc Gornet, Jaafar Bennouna, Olivier Bouché, Eric Francois, for Prodige investigators, Veronique Guerin-Meyer, Oana Cojocarasu, Marie-Christine Kaminsky, Joëlle Egreteau, Laetitia Dahan, Jean-Baptiste Bachet, François Ghiringhelli, Roger Faroux, Mohamed Gasmi, Thomas Aparicio, Christian Borel, and Côme Lepage
- Subjects
Male ,Oncology ,Cancer Research ,medicine.medical_specialty ,Multivariate analysis ,Colorectal cancer ,medicine.medical_treatment ,Logistic regression ,Article ,law.invention ,Free interval ,Prognostic markers ,03 medical and health sciences ,0302 clinical medicine ,Randomized controlled trial ,law ,Internal medicine ,medicine ,Humans ,Aged ,030304 developmental biology ,0303 health sciences ,Chemotherapy ,business.industry ,Induction chemotherapy ,Induction Chemotherapy ,medicine.disease ,Clinical trial ,030220 oncology & carcinogenesis ,Disease Progression ,Female ,Colorectal Neoplasms ,business - Abstract
Background Identifying patients with metastatic colorectal cancer who will have an early disease progression during induction chemotherapy (IC) and identifying patients who may have a chemotherapy-free interval (CFI) after IC are two major challenges. Methods A logistic model was used to identify factors associated with early progression during IC and with short duration of the first CFI in 488 patients enrolled in the PRODIGE 9 trial. Independent factors were defined with a threshold 0.10. Results In multivariate analysis, baseline leukocytes >10 × 109/L (OR = 1.98 [1.02–3.8], p = 0.04), and stable or increasing CEA at 2 months (OR = 3.61 [1.68–7.75], p = 0.01) were independent factors associated with progression during IC. Male gender (OR = 1.725 [0.92–3.325], p = 0.09) and no tumour response at first evaluation (OR = 1.90 [0.96–3.76], p = 0.07) were significantly associated with a short CFI. The presence of BRAF V600E mutation was also associated with short CFI (OR = 4.59 [0.95; 22.3], p = 0.058). Conclusion High baseline leukocyte count and the lack of CEA decrease level at first evaluation were associated with early progression, and could be in favour of early chemotherapy intensification. Male gender, no tumour response at first evaluation and BRAF mutation are associated with a short CFI, and may be considered for maintenance chemotherapy after IC. Clinical trial number NCT00952029.
- Published
- 2020
- Full Text
- View/download PDF
29. Tax expenditures in Alegria between costs and benefits.
- Author
-
Mohamed, Gasmi
- Published
- 2023
30. Endoscopic Ultrasound-Guided Gastroenteric Anastomosis: A French Center Experience
- Author
-
Marc Barthet, Mohamed Gasmi, JM Gonzalez, A Becar, and S Ouazzani
- Subjects
Endoscopic ultrasound ,medicine.medical_specialty ,medicine.diagnostic_test ,business.industry ,medicine ,Center (algebra and category theory) ,Anastomosis ,business ,Surgery - Published
- 2021
- Full Text
- View/download PDF
31. Endoscopic ultrasound-directed transgastrojejunal ERCP: a new technique to treat biliary stricture through the afferent limb after Whipple surgery
- Author
-
Marc Barthet, Jean-Michel Gonzalez, and Mohamed Gasmi
- Subjects
Endoscopic ultrasound ,Cholangiopancreatography, Endoscopic Retrograde ,Afferent limb ,medicine.medical_specialty ,Cholestasis ,medicine.diagnostic_test ,business.industry ,Gastroenterology ,MEDLINE ,Constriction, Pathologic ,Surgery ,Endosonography ,Pancreaticoduodenectomy ,Medicine ,Humans ,business ,Retrospective Studies - Published
- 2020
32. ENDOSCOPIC TREATMENT OF GASTROBRONCHIAL FISTULA AFTER SLEEVE GASTRECTOMY WITH INJECTION OF CYANOACRYLATE GLUE (WITH VIDEO)
- Author
-
S Berdat, JM Gonzalez, Xavier Benoit D’Journo, Mohamed Gasmi, Thierry Bege, Marc Barthet, and Laurent Monino
- Subjects
medicine.medical_specialty ,Sleeve gastrectomy ,Cyanoacrylate ,law ,business.industry ,medicine.medical_treatment ,Medicine ,GLUE ,business ,Endoscopic treatment ,law.invention ,Surgery ,Gastrobronchial fistula - Published
- 2020
- Full Text
- View/download PDF
33. WIRSUNGO-GASTRIC ANASTOMOSIS UNDER ENDOSCOPIC ULTRASOUND (EUS) IN THE MANAGEMENT OF SYMPTOMATIC DILATION OF THE MAIN PANCREATIC DUCT: A TERTIARY CENTER EXPERIENCE
- Author
-
JM Gonzalez, Mohamed Gasmi, Marc Barthet, Laurent Monino, and Arthur Falque
- Subjects
Endoscopic ultrasound ,Pancreatic duct ,medicine.medical_specialty ,medicine.anatomical_structure ,medicine.diagnostic_test ,business.industry ,Gastric anastomosis ,medicine ,Dilation (morphology) ,Radiology ,business - Published
- 2020
- Full Text
- View/download PDF
34. EUS-GUIDED RADIOFREQUENCY ABLATION MID-TERM RESULTS (MORE THAN TWO YEARS FOLLOW-UP) FOR PANCREATIC NEUROENDOCRINE TUMOR AND PANCREATIC CYSTIC NEOPLASMS
- Author
-
G Vanbervliet, N. Lesavre, Mohamed Gasmi, Marc Barthet, M Giovannini, Christian Boustière, JM Gonzalez, Stéphane Koch, and B. Napoléon
- Subjects
medicine.medical_specialty ,Pancreatic neuroendocrine tumor ,business.industry ,Radiofrequency ablation ,law ,medicine ,Mid term results ,Radiology ,business ,medicine.disease ,law.invention - Published
- 2020
- Full Text
- View/download PDF
35. ENDOSCOPIC MULTIMODAL EXTRA-GASTRIC PANCREATIC NECROSECTOMY: UNUSUAL AND MULTIPLE ACCESS ROUTES (WITH VIDEO CASES)
- Author
-
Laurent Monino, Mohamed Gasmi, JM Gonzalez, and Marc Barthet
- Subjects
medicine.medical_specialty ,Pancreatic necrosectomy ,business.industry ,General surgery ,medicine ,business - Published
- 2020
- Full Text
- View/download PDF
36. Artificial intelligence-guided tissue analysis combined with immune infiltrate assessment predicts stage III colon cancer outcomes in PETACC08 study
- Author
-
S. Nguyen, Quentin Klopfenstein, Oana Cojocarasu, Francis Fein, Mohamed Gasmi, Cynthia Reichling, Pierre-Laurent Puig, Karine Le Malicot, Jean Paul Lagasse, Côme Lepage, Pierre-Luc Etienne, Jean-Marc Gornet, Julien Taieb, Jean-François Emile, Hakim Becheur, Dominique Luet, François Ghiringhelli, André Vanoli, Hervé Perrier, Marie Christine Kaminsky, Valentin Derangère, Centre Régional de Lutte contre le cancer Georges-François Leclerc [Dijon] (UNICANCER/CRLCC-CGFL), and UNICANCER
- Subjects
0301 basic medicine ,Colorectal cancer ,Lymphocyte ,0302 clinical medicine ,Antineoplastic Combined Chemotherapy Protocols ,Medicine ,immunohistopathology ,MESH: Lymphocytes, Tumor-Infiltrating ,biology ,Gastroenterology ,MESH: Neoplasm Staging ,Prognosis ,3. Good health ,MESH: Antineoplastic Combined Chemotherapy Protocols ,medicine.anatomical_structure ,030220 oncology & carcinogenesis ,Colonic Neoplasms ,Stromal cell ,CD3 ,adjuvant treatment ,colorectal cancer ,[SDV.CAN]Life Sciences [q-bio]/Cancer ,Adenocarcinoma ,Disease-Free Survival ,MESH: Prognosis ,03 medical and health sciences ,Lymphocytes, Tumor-Infiltrating ,Immune system ,computerised image analysis ,Stroma ,Artificial Intelligence ,Image Interpretation, Computer-Assisted ,Humans ,MESH: Artificial Intelligence ,Neoplasm Invasiveness ,Pathological ,Neoplasm Staging ,MESH: Colonic Neoplasms ,MESH: Humans ,business.industry ,MESH: Adenocarcinoma ,MESH: Neoplasm Invasiveness ,medicine.disease ,030104 developmental biology ,MESH: Disease-Free Survival ,biology.protein ,Artificial intelligence ,[INFO.INFO-BI]Computer Science [cs]/Bioinformatics [q-bio.QM] ,business ,MESH: Image Interpretation, Computer-Assisted ,CD8 - Abstract
ObjectiveDiagnostic tests, such as Immunoscore, predict prognosis in patients with colon cancer. However, additional prognostic markers could be detected on pathological slides using artificial intelligence tools.DesignWe have developed a software to detect colon tumour, healthy mucosa, stroma and immune cells on CD3 and CD8 stained slides. The lymphocyte density and surface area were quantified automatically in the tumour core (TC) and invasive margin (IM). Using a LASSO algorithm, DGMate (DiGital tuMor pArameTErs), we detected digital parameters within the tumour cells related to patient outcomes.ResultsWithin the dataset of 1018 patients, we observed that a poorer relapse-free survival (RFS) was associated with high IM stromal area (HR 5.65; 95% CI 2.34 to 13.67; pConclusionThese findings suggest that artificial intelligence can potentially improve patient care by assisting pathologists in better defining stage III colon cancer patients’ prognosis.
- Published
- 2020
- Full Text
- View/download PDF
37. Distinct epigenetic landscapes underlie the pathobiology of pancreatic cancer subtypes
- Author
-
Angela Mathison, Huihuang Yan, Odile Gayet, Benjamin Bian, Laetitia Marisa, Véronique Secq, Jean Robert Delpero, Mohamed Gasmi, Vincent Moutardier, Gavin R. Oliver, Rémy Nicolle, Nelson Dusetti, Lucile Armenoult, Zhifu Sun, Philippe Grandval, Pauline Duconseil, Nabila Elarouci, Gwen Lomberk, Marine Gilabert, Martin Bigonnet, Eric W. Klee, Krutika S. Gaonkar, Stéphane Garcia, Aurélien de Reyniès, Mira Ayadi, Yuna Blum, Juan L. Iovanna, Asha Nair, Marc Giovannini, Raul Urrutia, Olivier Turrini, Jeong Heon Lee, Tamas Ordog, Medical College of Wisconsin, Ligue Nationale Contre le Cancer - Paris, Ligue Nationnale Contre le Cancer, Compartimentation et dynamique cellulaires (CDC), Institut Curie [Paris]-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), Université Paris sciences et lettres (PSL), Department of Health Sciences Research [Mayo Clinic] (HSR), Mayo Clinic, Department of Physiology and Biomedical Engineering, Mayo Clinic College of Medicine, Ultrasound Research Laboratory, Translational Epigenomics Program, Mayo Clinic-Center for Individualized Medicine (CIM), Centre de Recherche en Cancérologie de Marseille (CRCM), Aix Marseille Université (AMU)-Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Fédération nationale des Centres de lutte contre le Cancer (FNCLCC)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Institut Paoli-Calmettes, Fédération nationale des Centres de lutte contre le Cancer (FNCLCC), Département de Gastro-Entérologie [Hôpital de La Timone - APHM], Hôpital de la Timone [CHU - APHM] (TIMONE), Service De Gastroenterologie, Hôpital Nord, Assistance Publique-Hôpitaux de Marseille, Ligue Nationale Contre le Cancer (LNCC), and Bidaut, Ghislain
- Subjects
0301 basic medicine ,Male ,Epigenomics ,endocrine system diseases ,[SDV]Life Sciences [q-bio] ,General Physics and Astronomy ,Datasets as Topic ,Regulatory Sequences, Nucleic Acid ,Epigenesis, Genetic ,Histones ,Mice ,lcsh:Science ,Epigenesis ,Cancer ,Regulation of gene expression ,Aged, 80 and over ,Multidisciplinary ,biology ,Middle Aged ,3. Good health ,Chromatin ,[SDV] Life Sciences [q-bio] ,Gene Expression Regulation, Neoplastic ,Histone ,DNA methylation ,Female ,Carcinoma, Pancreatic Ductal ,Chromatin Immunoprecipitation ,Science ,Mice, Nude ,Computational biology ,General Biochemistry, Genetics and Molecular Biology ,Article ,03 medical and health sciences ,Pancreatic cancer ,Cell Line, Tumor ,medicine ,Biomarkers, Tumor ,Animals ,Humans ,Epigenetics ,Aged ,Sequence Analysis, RNA ,General Chemistry ,DNA Methylation ,medicine.disease ,Xenograft Model Antitumor Assays ,digestive system diseases ,Pancreatic Neoplasms ,030104 developmental biology ,biology.protein ,lcsh:Q - Abstract
Recent studies have offered ample insight into genome-wide expression patterns to define pancreatic ductal adenocarcinoma (PDAC) subtypes, although there remains a lack of knowledge regarding the underlying epigenomics of PDAC. Here we perform multi-parametric integrative analyses of chromatin immunoprecipitation-sequencing (ChIP-seq) on multiple histone modifications, RNA-sequencing (RNA-seq), and DNA methylation to define epigenomic landscapes for PDAC subtypes, which can predict their relative aggressiveness and survival. Moreover, we describe the state of promoters, enhancers, super-enhancers, euchromatic, and heterochromatic regions for each subtype. Further analyses indicate that the distinct epigenomic landscapes are regulated by different membrane-to-nucleus pathways. Inactivation of a basal-specific super-enhancer associated pathway reveals the existence of plasticity between subtypes. Thus, our study provides new insight into the epigenetic landscapes associated with the heterogeneity of PDAC, thereby increasing our mechanistic understanding of this disease, as well as offering potential new markers and therapeutic targets., Pancreatic ductal adenocarcinoma (PDAC) is a complex disease and its underlying epigenomic heterogeneity is not fully understood. Here, the authors utilize patient-derived PDAC xenografts to define the epigenomic landscape of PDAC, highlighting chromatin states linked to differing disease aggressiveness and survival.
- Published
- 2018
- Full Text
- View/download PDF
38. Drainage des abcès périrectaux sous échoendoscopie
- Author
-
Mohamed Gasmi, J.-M. Gonzalez, B. Aider, and Marc Barthet
- Subjects
03 medical and health sciences ,0302 clinical medicine ,business.industry ,030220 oncology & carcinogenesis ,Medicine ,030211 gastroenterology & hepatology ,Radiology, Nuclear Medicine and imaging ,Nuclear medicine ,business - Published
- 2018
- Full Text
- View/download PDF
39. Contributions of gravity and field data on the structural scheme updating of the Tellian domain and its foreland (Nefza-Bizerte region, northern Tunisia)
- Author
-
Hadhemi Balti, El Mabrouk Essid, Fouad Zargouni, Mohamed Gasmi, and Ali Kadri
- Subjects
010504 meteorology & atmospheric sciences ,Outcrop ,010502 geochemistry & geophysics ,Neogene ,01 natural sciences ,Graben ,Tectonics ,Paleontology ,Magmatism ,General Earth and Planetary Sciences ,Structural geology ,Foreland basin ,Bouguer anomaly ,Geology ,0105 earth and related environmental sciences - Abstract
The Nefza-Bizerte region, eastern part of the Tunisian Alpine chain, covers the thrust sheets domain called the Tell and its Atlassic foreland. The deep structures under the Tellian thrust sheets are not enough explored. The structural interpretation of magmatic rocks, Triassic outcrops and the depressions are still a subject of discussion. In this work, we intend to investigate deep faults and their eventual role in magmatism and Triassic salt setting up and to explain the depression genesis. Analysis of the Bouguer anomaly map and its derivatives reveals the main gravity lineaments, organized in major NE- and NW-trending systems. The NE-trending system, dipping towards the NW, is the main component of the structural scheme and has controlled the tectonic evolution of this area. After the immobilization of the Tellian thrust sheets during the uppermost Langhian, the Tell and its Atlassic foreland were affected by the Tortonian compressive event with a NW-trending maximum horizontal stress. The reverse kinematics of the NE-trending deep-seated faults created at their front continental environments filled later by post-nappes Neogene deposits. After the early Pleistocene, a NNW-directed compressional stress regime deformed the post-nappes Neogene series and generated NW-trending grabens. This coexistence of compression-extension continues until present day.
- Published
- 2018
- Full Text
- View/download PDF
40. Geriatric Profile of Elderly Patients Treated For Pancreatic Cancer: The Oncogepan Database
- Author
-
Jean-Robert Delpero, Camille Sibertin-Blanc, Maud Cecile, Emilie Nouguerède, Frédérique Rousseau, Emmanuelle Norguet, Marc Giovannini, Mohamed Gasmi, Vincent Moutardier, Jean-Luc Raoul, Lilian Laborde, Jean-François Seitz, Cecile Braticevic, Alban Macagno, and Elodie Cretel Durand
- Subjects
Oncology ,medicine.medical_specialty ,business.industry ,Internal medicine ,Pancreatic cancer ,medicine ,medicine.disease ,business - Published
- 2017
- Full Text
- View/download PDF
41. Endoscopic ultrasound-guided colojejunal anastomosis: new treatment management for enteral occlusion
- Author
-
Mohamed Gasmi, Arthur Falque, Jean-Michel Gonzalez, and Marc Barthet
- Subjects
Endoscopic ultrasound ,medicine.medical_specialty ,medicine.diagnostic_test ,business.industry ,Anastomosis, Surgical ,Gastroenterology ,MEDLINE ,Anastomosis ,Enteral administration ,Endosonography ,Surgery ,Treatment management ,Intestine, Small ,Occlusion ,medicine ,Humans ,business ,Intestinal Obstruction ,Ultrasonography, Interventional - Published
- 2020
- Full Text
- View/download PDF
42. Endoscopic rendezvous recanalization for complete anastomotic obstruction after retrosternal coloplasty: a novel approach through a cervicotomy
- Author
-
Marc Barthet, Pascal Thomas, Xavier Benoit D’Journo, Mohamed Gasmi, Abel Tadrist, Mathieu Rouy, and Michael Baboudjian
- Subjects
medicine.medical_specialty ,business.industry ,Anastomosis, Surgical ,Gastroenterology ,Rendezvous ,MEDLINE ,Anastomosis ,Endosonography ,Surgery ,Young Adult ,medicine ,Humans ,Female ,Esophagoscopy ,business - Published
- 2020
- Full Text
- View/download PDF
43. Fertility preservation strategies for rectal cancer in reproductive-age women
- Author
-
Jacqueline Saias-Magnan, Mohamed Gasmi, Pierre Orsoni, Blandine Courbiere, Groupe de Recherche et d'Etude en Cryoconservation Ovarienne et Testiculaire, Samuel Khiat, Pauline Bottin, Centre Clinico-Biologique d’Assistance Médicale à la Procréation - CECOS [Hôpital de la Conception - APHM], Hôpital de la Conception [CHU - APHM] (LA CONCEPTION), Hôpital Nord [CHU - APHM], Aix Marseille Université (AMU), Service de Gynécologie et Obstétrique [Marseille], Institut méditerranéen de biodiversité et d'écologie marine et continentale (IMBE), and Avignon Université (AU)-Aix Marseille Université (AMU)-Institut de recherche pour le développement [IRD] : UMR237-Centre National de la Recherche Scientifique (CNRS)
- Subjects
Adult ,Cancer Research ,medicine.medical_specialty ,Ovarian Cortex ,Colorectal cancer ,media_common.quotation_subject ,Rectum ,Fertility ,[SDV.CAN]Life Sciences [q-bio]/Cancer ,[SDV.MHEP.GEO]Life Sciences [q-bio]/Human health and pathology/Gynecology and obstetrics ,ovarian transposition ,03 medical and health sciences ,0302 clinical medicine ,medicine ,Humans ,Ovarian tissue cryopreservation ,Fertility preservation ,rectal cancer ,Oncofertility ,media_common ,Cryopreservation ,030219 obstetrics & reproductive medicine ,ovarian tissue cryopreservation ,business.industry ,Obstetrics ,Rectal Neoplasms ,Reproduction ,Ovary ,Fertility Preservation ,General Medicine ,medicine.disease ,Vitrification ,3. Good health ,Premature ovarian failure ,medicine.anatomical_structure ,Oncology ,030220 oncology & carcinogenesis ,oocyte vitrification ,Oocytes ,Female ,France ,business - Abstract
International audience; Despite rectal cancer being unusual before 40, fertility preservation (FP) remains a major concern for these reproductive-age women. Treatment usually involves pelvic radiotherapy, neoadjuvant chemotherapy, and surgery of rectum and mesorectum resection, at high risk of impairing fertility in women with risks of premature ovarian failure and radio-induced uterus damage. To date, there is no consensus on FP strategy for rectal cancer. We shared experiences between oncofertility experts from a French research network Groupe de Recherche et d'Etude en Cryoconservation Ovarienne et Testiculaire about a case of rectal cancer in a young woman. Indications, advantages and disadvantages of different FP strategies were discussed: ovarian transposition, cryopreservation of ovarian cortex and oocyte vitrification. This case was the starting point that led to the development of a French multidisciplinary e-meeting for sharing experiences and for suggesting the best strategy when faced with a complex oncofertility case.
- Published
- 2019
- Full Text
- View/download PDF
44. Incidence of Venous Thromboembolism in Patients With Newly Diagnosed Pancreatic Cancer and Factors Associated With Outcomes
- Author
-
Corinne Frere, Barbara Bournet, Sophie Gourgou, Julien Fraisse, Cindy Canivet, Jean M. Connors, Louis Buscail, Dominique Farge, Nicolas Carrère, Fabrice Muscari, Bertrand Suc, Rosine Guimbaud, Corinne Couteau, Marion Deslandres, Pascale Rivera, Anne-Pascale Laurenty, Nadim Fares, Karl Barange, Janick Selves, Anne Gomez-Brouchet, Bertrand Napoléon, Bertrand Pujol, Fabien Fumex, Jérôme Desrame, Christine Lefort, Vincent Lepilliez, Rodica Gincul, Pascal Artru, Léa Clavel, Anne-Isabelle Lemaistre, Laurent Palazzo, Jérôme Cros, Sarah Tubiana, Nicolas Flori, Pierre Senesse, Pierre-Emmanuel Colombo, Emmanuelle Samail-Scalzi, Fabienne Portales, Claire Honfo Ga, Carine Plassot, Frédéric Bibeau, Marc Ychou, Pierre Guibert, Christelle de la Fouchardière, Matthieu Sarabi, Patrice Peyrat, Séverine Tabone-Eglinger, Caroline Renard, Guillaume Piessen, Stéphanie Truant, Alain Saudemont, Guillaume Millet, Florence Renaud, Emmanuelle Leteurtre, Patrick Gele, Eric Assenat, Jean-Michel Fabre, François-Régis Souche, Marie Dupuy, Anne-Marie Gorce-Dupuy, Jeanne Ramos, Jean-François Seitz, Jean Hardwigsen, Emmanuelle Norguet-Monnereau, Philippe Grandval, Muriel Duluc, Dominique Figarella-Branger, Véronique Vendrely, Clément Subtil, Eric Terrebonne, Jean-Frédéric Blanc, Etienne Buscail, Jean-Philippe Merlio, Jean-Marc Gornet, Daniela Geromin, Geoffroy Vanbiervliet, Anne-Claire Frin, Delphine Ouvrier, Marie-Christine Saint-Paul, Philippe Berthelémy, Chelbabi Fouad, Stéphane Garcia, Nathalie Lesavre, Mohamed Gasmi, Marc Barthet, Vanessa Cottet, Cyrille Delpierre, CCSD, Accord Elsevier, Unité de Recherche sur les Maladies Cardiovasculaires, du Métabolisme et de la Nutrition = Research Unit on Cardiovascular and Metabolic Diseases (ICAN), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Institut de Cardiométabolisme et Nutrition = Institute of Cardiometabolism and Nutrition [CHU Pitié Salpêtrière] (IHU ICAN), CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Institut de médecine moléculaire de Rangueil (I2MR), Université Toulouse III - Paul Sabatier (UT3), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées- Institut Fédératif de Recherche Bio-médicale Institution (IFR150)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), Institut de Recherche en Cancérologie de Montpellier (IRCM - U1194 Inserm - UM), CRLCC Val d'Aurelle - Paul Lamarque-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Montpellier (UM), Unité de biostatistiques, CRLCC Val d'Aurelle - Paul Lamarque, Brigham & Women’s Hospital [Boston] (BWH), Harvard Medical School [Boston] (HMS), McGill University Health Center [Montreal] (MUHC), Hopital Saint-Louis [AP-HP] (AP-HP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Unité de Recherche sur les Maladies Cardiovasculaires, du Métabolisme et de la Nutrition = Institute of cardiometabolism and nutrition (ICAN), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [AP-HP], Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Université Fédérale Toulouse Midi-Pyrénées-Université Fédérale Toulouse Midi-Pyrénées-IFR150-Institut National de la Santé et de la Recherche Médicale (INSERM), and CHU Toulouse [Toulouse]
- Subjects
0301 basic medicine ,Adult ,Male ,medicine.medical_specialty ,Time Factors ,medicine.drug_class ,Low molecular weight heparin ,Pancreatic Cancer ,03 medical and health sciences ,0302 clinical medicine ,Risk Factors ,Internal medicine ,Clinical endpoint ,medicine ,Humans ,Cumulative incidence ,cardiovascular diseases ,Progression-free survival ,Prospective Studies ,Aged ,Neoplasm Staging ,Aged, 80 and over ,[SDV.MHEP] Life Sciences [q-bio]/Human health and pathology ,Hepatology ,business.industry ,Prognostic Factor ,Incidence (epidemiology) ,Incidence ,Hazard ratio ,Gastroenterology ,Venous Thromboembolism ,Middle Aged ,medicine.disease ,Primary tumor ,Confidence interval ,Progression-Free Survival ,3. Good health ,Pancreatic Neoplasms ,030104 developmental biology ,030211 gastroenterology & hepatology ,Female ,Blood Clot ,France ,business ,Complication ,[SDV.MHEP]Life Sciences [q-bio]/Human health and pathology ,Carcinoma, Pancreatic Ductal ,Follow-Up Studies - Abstract
International audience; Background & aims: Pancreatic ductal adenocarcinoma (PDAC) is associated with the highest incidence of venous thromboembolism (VTE) of any cancer type. However, little is known about risk factors for VTE or its outcomes in patients with PDAC.Methods: We collected data from a prospective, observational study performed at multiple centers in France from May 2014 through November 2018 (the Base Clinico-Biologique de l'Adénocarcinome Pancréatique [BACAP] study) linked to a database of patients with a new diagnosis of PDAC of any stage. Data were collected from 731 patients at baseline and during clinical follow-up or in the event of symptoms. The primary endpoint was the onset of VTE during follow-up. The secondary endpoints were progression-free survival (PFS) and overall survival (OS) times.Results: During a median follow-up of 19.3 months, 152 patients (20.79%) developed a VTE. The median time from PDAC diagnosis to the onset of VTE was 4.49 months. Cumulative incidence values of VTE were 8.07% (95% confidence interval [CI], 6.31-10.29) at 3 months and 19.21% (95% CI, 16.27-22.62) at 12 months. In multivariate analysis, PDAC primary tumor location (isthmus vs head: hazard ratio [HR], 2.06; 95% CI, 1.09-3.91; P = .027) and stage (locally advanced vs resectable or borderline: HR, 1.66; 95% CI, 1.10-2.51, P = .016; metastatic vs resectable or borderline: HR, 2.50; 95% CI, 1.64-3.79; P < .001) were independent risk factors for the onset of VTE. Patients who developed VTE during follow-up had shorter times of PFS (HR, 1.74; 95% CI, 1.19-2.54; P = .004) and OS (HR, 2.02; 95% CI, 1.57-2.60; P < .001).Conclusion: In an analysis of data from the BACAP study, we found that frequent and early onsets of VTE after diagnoses of PDAC are associated with significant decreases in times of PFS and OS. Studies are needed to determine whether primary prophylaxis of VTE in patients with PDAC will improve morbidity and mortality related to VTE. (ClinicalTrials.gov, Number: clinicaltrials.gov as number NCT02818829).
- Published
- 2019
- Full Text
- View/download PDF
45. EUS-GUIDED TANS-RECTAL TREATMENT FOR SYMPTOMATIC PELVIC COLLECTIONS: PUNCTURE/ASPIRATION OR DRAINAGE? RESULTS FROM A LARGE MONOCENTRIC STUDY
- Author
-
JM Gonzalez, Marine Guingand, Mohamed Gasmi, and Marc Barthet
- Subjects
medicine.medical_specialty ,business.industry ,Medicine ,Drainage ,business ,Surgery - Published
- 2019
- Full Text
- View/download PDF
46. ANTEROGRADE BILIARY DRAINAGE AS SECOND STEP AFTER EUS HEPATICOGASTROSTOMY (ABD-HG) FOR MANAGING BENIGN BILIO-DIGESTIVE ANASTOMOTIC STRICTURES
- Author
-
J Bodiou, Marc Barthet, Mohamed Gasmi, and JM Gonzalez
- Subjects
medicine.medical_specialty ,Biliary drainage ,Hepaticogastrostomy ,business.industry ,Medicine ,Anastomosis ,business ,Surgery - Published
- 2019
- Full Text
- View/download PDF
47. Contribution of electrical prospecting to the characterization of aquifers in the North Gabes-El Hamma region (Southern Tunisia)
- Author
-
Hadhemi Balti, Sabeh Ben Ghaffar, Mohamed Gasmi, Mouna Ben Alayet, and Sabrine Zaghdoudi
- Subjects
geography ,Hydrogeology ,geography.geographical_feature_category ,010504 meteorology & atmospheric sciences ,Borehole ,Geology ,Aquifer ,010502 geochemistry & geophysics ,01 natural sciences ,Graben ,chemistry.chemical_compound ,chemistry ,Prospecting ,Carbonate ,Petrology ,Isopach map ,Groundwater ,0105 earth and related environmental sciences ,Earth-Surface Processes - Abstract
The North Gabes-El Hamma region is located in the south of Tunisia at the northern limit of the Saharan platform. It has been the subject of several geological, mining and especially hydrogeological studies. These studies aim to evaluate the underground water potentialities of this region in order to exploit them in a rational way. It is within this framework that the present study is carried out, and it concerns the reinterpretation of 124 Vertical Electrical Soundings (VES) covering the study area. This study aims first to highlight aquifers and then to characterize them geometrically (thickness, depth and lateral extensions). To achieve this, the interpretation of the VES was carried out first in a qualitative way (establishment of apparent iso-resistivity maps and pseudosections) and then in a quantitative way (calibration of the VES on water boreholes, establishment of geoelectric sections and the roofs isobath and isopach maps of aquifer levels). From the hydrostratigraphic point of view, the results show that the North Gabes-El Hamma region is characterized by the presence of two aquifers. The first one is superficial, with limited potentialities and would be constituted by heterogeneous silico-clastic series of mio-plio-quaternary age (MPQ) characterized by geoelectric levels of quite variable resistivities. The second aquifer is deeper, with higher potentialities and would be constituted by Lower Senonian carbonate series (SIC) characterized by resistivities between 15 and 28 Ω m. From the structural point of view, the region is affected by intense fracturing in two main directions: NE-SW and NW-SE. The role of these faults, some of which are already known, is very important since they have subdivided the region into high zones (horsts) where the SIC would be eroded (with variable intensities) and low zones (grabens) where the SIC would be preserved under a thick MPQ cover. Moreover, these faults facilitate the lateral and especially vertical flow of groundwater and contribute to intercommunication between aquifers. In order to orient and rationalize the exploitation of the different aquifers of the North Gabes-El Hamma region, a synthetic map presenting their characteristics (geographical distribution and depths) has been established.
- Published
- 2021
- Full Text
- View/download PDF
48. A pancreatic ductal adenocarcinoma subpopulation is sensitive to FK866, an inhibitor of NAMPT
- Author
-
Marine Barraud, Flora Poizat, Juan L. Iovanna, Jean-Robert Delpero, Aurélie Maignan, Marc Giovannini, Celine Loncle, Vincent Moutardier, Véronique Secq, Nelson Dusetti, Olivier Turrini, N. Guibert, Marine Gilabert, Philippe Grandval, Pauline Duconseil, Charlotte Lequeue, Benjamin Bian, Stéphane Garcia, Mohamed Gasmi, Jonathan Garnier, Mehdi Ouaissi, Sophie Vasseur, Martin Bigonnet, and Odile Gayet
- Subjects
Male ,0301 basic medicine ,FK866 ,pancreatic cancer ,Nicotinamide phosphoribosyltransferase ,chemotherapy ,NAMPT ,Mice ,chemistry.chemical_compound ,0302 clinical medicine ,Piperidines ,Tumor Cells, Cultured ,Enzyme Inhibitors ,Nicotinamide Phosphoribosyltransferase ,Aged, 80 and over ,Middle Aged ,Oncology ,030220 oncology & carcinogenesis ,Cytokines ,Biomarker (medicine) ,Female ,Carcinoma, Pancreatic Ductal ,Research Paper ,medicine.drug ,Adult ,medicine.medical_specialty ,Stromal cell ,Antineoplastic Agents ,03 medical and health sciences ,Pancreatic cancer ,Biomarkers, Tumor ,medicine ,Animals ,Humans ,Viability assay ,Aged ,Acrylamides ,business.industry ,Cancer ,medicine.disease ,Xenograft Model Antitumor Assays ,Gemcitabine ,Surgery ,Oxaliplatin ,Pancreatic Neoplasms ,030104 developmental biology ,chemistry ,Drug Resistance, Neoplasm ,Cancer research ,business - Abstract
Treating pancreatic cancer is extremely challenging due to multiple factors, including chemoresistance and poor disease prognosis. Chemoresistance can be explained by: the presence of a dense stromal barrier leading to a lower vascularized condition, therefore limiting drug delivery; the huge intra-tumoral heterogeneity; and the status of epithelial-to-mesenchymal transition. These factors are highly variable between patients making it difficult to predict responses to chemotherapy. Nicotinamide phosphoribosyl transferase (NAMPT) is the main enzyme responsible for recycling cytosolic NAD+ in hypoxic conditions. FK866 is a noncompetitive specific inhibitor of NAMPT, which has proven anti-tumoral effects, although a clinical advantage has still not been demonstrated. Here, we tested the effect of FK866 on pancreatic cancer-derived primary cell cultures (PCCs), both alone and in combination with three different drugs typically used against this cancer: gemcitabine, 5-Fluorouracil (5FU) and oxaliplatin. The aims of this study were to evaluate the benefit of drug combinations, define groups of sensitivity, and identify a potential biomarker for predicting treatment sensitivity. We performed cell viability tests in the presence of either FK866 alone or in combination with the drugs above-mentioned. We confirmed both inter- and intra-tumoral heterogeneity. Interestingly, only the in vitro effect of gemcitabine was influenced by the addition of FK866. We also found that NAMPT mRNA expression levels can predict the sensitivity of cells to FK866. Overall, our results suggest that patients with tumors sensitive to FK866 can be identified using NAMPT mRNA levels as a biomarker and could therefore benefit from a co-treatment of gemcitabine plus FK866.
- Published
- 2016
- Full Text
- View/download PDF
49. Efficacy of the endoscopic management of postoperative fistulas of leakages after esophageal surgery for cancer: a retrospective series
- Author
-
Mohamed Gasmi, Jean-Michel Gonzalez, Jean-Charles Grimaud, M Leone, B. Aider, C Servajean, Xavier Benoit D’Journo, Marc Barthet, Department of Gastroenterology, APHM, North Hospital,University of Mediterranean, Image et ville (IV), Université Louis Pasteur - Strasbourg I-Centre National de la Recherche Scientifique (CNRS), Unité de Recherche sur les Maladies Infectieuses et Tropicales Emergentes (URMITE), Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR48, INSB-INSB-Centre National de la Recherche Scientifique (CNRS), Hôpital Nord [CHU - APHM], and Institut des sciences biologiques (INSB-CNRS)-Institut des sciences biologiques (INSB-CNRS)-Centre National de la Recherche Scientifique (CNRS)
- Subjects
Adult ,Male ,medicine.medical_specialty ,Esophageal Neoplasms ,medicine.medical_treatment ,Anastomotic Leak ,Adenocarcinoma ,Anastomosis ,Esophageal Fistula ,03 medical and health sciences ,Esophagus ,Postoperative Complications ,0302 clinical medicine ,[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases ,medicine ,Humans ,Aged ,Retrospective Studies ,Aged, 80 and over ,medicine.diagnostic_test ,business.industry ,Endoscopy ,Retrospective cohort study ,Middle Aged ,Esophageal cancer ,Surgical Instruments ,medicine.disease ,3. Good health ,Surgery ,Treatment Outcome ,medicine.anatomical_structure ,030220 oncology & carcinogenesis ,Therapeutic endoscopy ,Carcinoma, Squamous Cell ,Female ,Stents ,030211 gastroenterology & hepatology ,Esophagoscopy ,Radiology ,business ,Abdominal surgery - Abstract
International audience; Anastomotic leakages are severe and often lethal adverse events of surgery for esophageal cancer. The endoscopic treatment is growing up in such indications. The aim was to evaluate the efficacy and describe the strategy of the endoscopic management of anastomotic leakages/fistulas after esophageal oncologic surgery. Single-center retrospective study on 126 patients operated for esophageal carcinomas between 2010 and 2014. Thirty-five patients with postoperative fistulas/leakages (27 %) were endoscopically managed and included. The primary endpoint was the efficacy of the endoscopic treatment. The secondary endpoints were: delays between surgery, diagnosis, endoscopy and recovery; number of procedures; material used; and adverse events rate. Uni- and multivariate analyses were carried out to determine predictive factors of success. There were mostly men, with a median age of 61.7 years +/- 8.9 [43-85]. 48.6 % underwent Lewis-Santy surgery and 45.7 % Akiyama's. 71.4 % patients received neo-adjuvant chemo-radiation therapy. The primary and secondary efficacy was 48.6 and 68.6 %, respectively. The delay between surgery and endoscopy was 8.5 days [6.00-18.25]. Eighty-eight percentages of the patients were treated using double-type metallic stents, with removability and migration rates of 100 and 18 %, respectively. In the other cases, we used over-the-scope clips, naso-cystic drain or combined approach. The mean number of endoscopy was 2.6 +/- 1.57 [1-10]. The mortality rate was 17 %, none being related to procedures. No predictive factor of efficacy could be identified. The endoscopic management of leakages or fistulas after esophageal surgery reached an efficacy rate of 68.8 %, mostly using stents, without significant adverse events. The mortality rate could be decreased from 40-100 to 17 %.
- Published
- 2016
- Full Text
- View/download PDF
50. Genesis and structural arrangement of the collapsed Oued Gueniche plain and the surrounding folds (Neogene molassic basin of Bizerte, northeastern Tunisia): Insights from gravity data
- Author
-
Ali Kadri, Sabrine Zaghdoudi, El Mabrouk Essid, Mouna Ben Alayet, Mohamed Gasmi, and Mohamed Aymen Bounasri
- Subjects
010504 meteorology & atmospheric sciences ,Lineament ,Inversion (geology) ,Geology ,Structural basin ,Diapir ,010502 geochemistry & geophysics ,Geologic map ,Neogene ,01 natural sciences ,Geomorphology ,Palaeogeography ,Bouguer anomaly ,0105 earth and related environmental sciences ,Earth-Surface Processes - Abstract
The Oued Gueniche plain is located in the northeastern Tunisia. It is a part of the Bizerte Neogene molassic basin, developed at the front of the Alpine chain (The Maghrebides). The subsurface structure of this area is not enough explored and was subject of controversial interpretations. Gravity and seismic data acquired in the northeast of Tunisia were used to specify the subsurface structural configuration and the formation mechanism of the Oued Gueniche plain, as well as, its relationship with the surrounding folds. A total number of 664 gravity measurements were used to define the density distributions below the surface in the study area. The complete Bouguer gravity anomaly was performed with a reduction density of 2.4 g/cm3. Bouguer anomalies range from 9.5 to 34.8 mGal, high anomalies coincide with the Oued Gueniche plain in the northwest while weak anomalies are located on the southern part of the study area. The main NE-SW anomalies are superposed to the geological structures. The power spectrum of gravity data shows that the calculated average depth to the top of regional gravity sources is approximately 4 km while that of local (or residual) sources is approximately 0.6 km. The techniques for locating the limits of anomalous structures and estimating their depths (tilt derivative (TDR), Euler deconvolution (ED) and analytical signal (AS)) were applied to the Bouguer anomaly map to further specify the underground geological characteristics. The maxima of the horizontal gradient magnitudes (MGH) of Bouguer anomalies, upward continuated at different altitudes, revealed several NE-SW and E-W trending lineaments. A three-dimensional (3D) inversion model of gravity data has been developed for the Oued Gueniche plain in order to follow the distribution of densities. In addition, the interpretation of seismic profiles indicates that the central part of this plain is marked by the diapirism of Triassic rocks. The combination of these results with those of the surface (geological map and shallow hydrogeological boreholes) has led us to propose a kinematic model of the Bizerte region since the Middle Miocene and to update the structural scheme. Then, the NE-SW major faults (e.g. the newly defined Sfaia-Metline fault) and the NW-SE secondary ones have controlled the paleogeography and the structuration of the study area.
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.